Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Renin angiotensin system blockade: diabetes nephropathy

Trial Profile

Renin angiotensin system blockade: diabetes nephropathy

Phase of Trial: Phase II

Latest Information Update: 26 Jun 2011

At a glance

  • Drugs Enalapril; Losartan
  • Indications Diabetic nephropathies; Diabetic retinopathy
  • Focus Therapeutic Use
  • Acronyms B-RASS; RASS
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Jul 2009 Results were published in the New England Journal of Medicine.
    • 05 Nov 2008 New source identified and integrated (ClinicalTrials.gov record NCT00143949).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top